Resource Center
Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.
In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.
Resources
Publications
PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
2021 01 31
Campbell, C.I., Saxon, A.J., Boudreau, D.M., Wartko, P.D., Bobb, J.F., Lee, A.K., Matthews, A.G., McCormack, J., Liu, D.S., Addis, M., Altschuler, A., Samet, J.H., LaBelle, C.T., Arnsten, J., Caldeiro, R.M., Borst, D.T., Stotts, A.L., Braciszewski, J.M., Szapocznik, J., Bart, G., Schwartz, R.P., McNeely, J., Liebschutz, J.M., Tsui, J.I., Merrill, J.O., Glass, J.E., Lapham, G.T., Murphy, S.M., Weinstein, Z.M., Yarborough, B.Jo H., Bradley, K.A.
Diagnosis of Myelodysplastic Syndromes and Related Conditions: Rates of Discordance between Local and Central Review in the NHLBI MDS Natural History Study
Nov 29
Zhang, L., Stablein, D.M., Epling-Burnette, P.K., Harrington, A.M., Moscinski, L.C., Kroft, S., DeZern, A.E., Baghdadi, A., Liu, J.J., Walter, M.J., Bejar, R., EJ, G., Komrokji, R.S., Abel, G.A., Scott, B.L., Gore, S.D., Sekeres, M.A.
Clonal Cytopenias of Undetermined Significance Are Common in Cytopenic Adults Evaluated for MDS in the National MDS Study
Nov 13
Goll, J.B., Coleman, L.R., Hooper, W.F., Bejar, R., Walker, J., Fulton, R., Abel, G.A., Baghdadi, A., Deeg, H.J., DeZern, A.E., Ebert, B., Epling-Burnette, P., Foran, J.M., Gorak, E.J., Gore, S.D., Komrokji, R.S., Liu, J.J., Maciejewski, J.P., Padron, E., Saber, W., Starczynowski, D.T., Waclawiw, M., DiFronzo, N., Sekeres, M.A., Zhang, L., Walter, M.J.
Patient-Reported Outcomes and Frailty Among Participants in the NHLBI MDS Natural History Study
Dec 5
Abel, G.A., Hebert, D., Lee, C., Foran, J.M., Gore, S., Saber, W., Rollison, D., E, P., Wilson, S., Thompson, J., Waclawiw, M., DeFronzo, N.L., Sekeres, M.A.
Targeted Sequencing of 7 Genes Can Help Reduce Pathologic Misclassification of MDS
11/2020
Goll, J.B., Jensen, T.L., Lindsley, C., Bejar, R., Walker, J., Fulton, R., Abel, G.A., Baghdadi, T.Al, Deeg, J., DeZern, A.E., Ebert, B.L., Foran, J.M., Gorak, E.J., Gore, S.D., Komrokji, R., Liu, J.Jijun, Maciejewski, J.P., Padron, E., Saber, W., Starczynowski, D., Waclawiw, M., Wilson, S.H., Hebert, D., Reed, H., DiFronzo, N.L., Sekeres, M.A., Harrington, A.M., Kroft, S.H., Zhang, L.
Spectral Domain Optical Coherence Tomography Predictors of Visual Acuity in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2).
2020 Dec 26
Etheridge, T., Blodi, B., Oden, N., Van Veldhuisen, P., Scott, I.U., Ip, M.S., Mititelu, M., Domalpally, A.
Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents : SCORE2 report 12: secondary analysis of the SCORE2 clinical trial.
07/2021
Khurana, R.N., Oden, N.L., VanVeldhuisen, P.C., Scott, I.U., Blodi, B.A., Ip, M.S.
Improved Clinical Outcomes with Omidubicel versus Standard Myeloablative Umbilical Cord Blood Transplantation: Results of a Phase III Randomized, Multicenter Study
Horwitz, M.E., tiff, P., Rezvani, A.R., Hwang, W.Ying Khee, Karras, N., Valcarcel, D., Koh, L.Piu, yasser, K., Keating, A.K., Segalovich, I., Sanz, G., Cutler, C., Brunstein, C.G., Hanna, R., McGuirk, J.P., Lindemans, C.A., Maziarz, R.T., Schiller, G.J., Hammerschlak, N., Frankfurt, O., Blackwell, B., Galamidi, E.
The Influence of ICF and ICF Core Sets in Selecting the NINDS Cerebral Palsy Common Data Element Outcome Measures
Brandenburg, J., Schiariti, V., Mendoza-Puccini, C., Feldman, R., Joseph, K., Esterlitz, Jon behalf